Skip to main content
. 2016 Jan 6;12(1):e1005755. doi: 10.1371/journal.pgen.1005755

Fig 6. Patient specific analysis of negative RAD genes.

Fig 6

A) Top biological pathways molecular functions for every patient’s set of significant preferentially expressed alleles. B) Druggable targets in every patient. The bar plots show the extent of preferential allele expression and the list is sorted by the average of allelic expression from highest to lowest. Drugs in bold type are used in current anticancer treatment or undergoing clinical anticancer trials. C) Network plots of a selected pathway in every patient showing a druggable target.